Cyanobacteria-derived microcystin-leucine-arginine (MCLR), commonly characterized as a hepatotoxin, has recently been found to show neurotoxicity, but the exact mechanism is still unknown. To further our understanding of the neurotoxic effects of MCLR and the mechanisms behind it, we used two-dimensional gel electrophoresis and mass spectrometry analysis to identify global protein profiles associated with MCLR-induced neurotoxicity. MCLR-treated hippocampi showed alterations in proteins involved in cytoskeleton, neurodegenerative disease, oxidative stress, apoptosis, and energy metabolism. After validation by Western blot and quantitative real-time PCR, the expression of three proteins related to neurodegenerative disease, septin 5, α-internexin and α-synuclein was identified to be altered by MCLR exposure. Based on our proteomic analysis that MCLR toxicity might be linked to neurodegeneration, we examined the activity of serine/threonine-specific protein phosphatases (PPs) which is also reported as marker of neurodegenerative disease. MCLR was found to induce inhibition of PPs and abnormal hyperphosphorylation of the neuronal microtubule-associated protein tau. This was found to lead to impairment of learning and memory, accompanied by severe histological damage and neuronal apoptosis in the hippocampal CA1 regions of rats. Our results support the hypothesis that MCLR could induce neurotoxic effects and the reason of which could be contributed to the disruption of the cytoskeleton, oxidative stress and inhibition of PPs in the hippocampus. Moreover, MCLR was found to induce tau hyperphosphorylation, spatial memory impairment, neuronal degenerative changes and apoptosis, suggesting that this cyanotoxin may contribute to Alzheimer's disease in humans.
Introduction
The contamination of water by toxic blooms of cyanobacteria (blue-green algae) has occurred in many eutrophic inland waters worldwide. It exerts severe adverse health effects on humans and livestock by virtue of their ability to produce the heptatotoxin, microcystins (MCs) (Paerl et al., 2001; Dietrich et al., 2008; Falconer & Humpage, 2005; Teixera et al., 1993) . So far, more than 80 different structural analogues of MCs have been identified. Among these, microcystin-leucine-arginine (MCLR) is the most common and most toxic variant (Meriluoto & Spoof, 2008; Fastner et al., 2002) .
Several pieces of evidence suggest that MCs are also neurotoxic. Experimental animal studies have shown that MCs can cross the blood-brain-barrier and accumulate in the brains of aquatic and terrestrial animals (Fischer & Dietrich, 2000; Cazenave et al., 2008; Ding et al., 2006; Wang et al., 2008a; Meriluoto et al., 1990; Nishiwaki et al., 1994) . In neurotoxicity studies in fish, Cazenvave et al. (2008) reported changes in swimming activity of Jenynsia multidentata exposed to water-dissolved MCs. In mammals, memory loss has been observed in rats after intra-hippocampal infusion of a MCLR variant (Maidana et al., 2006) . The progeny of Swiss Albino mice exposed to cyanobacterial bloom extract containing MCs showed reduced brain size, indicating probable neurotoxicity (Falconer et al., 1988) . In humans, the most tragic incident associated with neurotoxicity of MCs was reported in a hemodialysis unit in Caruaru, Brazil in 1996. Among the 131 hemodialysis patients inadvertently exposed to various concentrations of MCs, 89% of them presented immediate signs of neurotoxicity (dizziness, tinnitus, vertigo, headache, vomiting, nausea, mild deafness, visual disturbance, and blindness) (Carmichael et al., 2001; Soares et al., 2006) . Previous evidence on the presence of cyanotoxins in brain and 4 cerebrospinal fluid samples of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD) victims has indicated the possibility that cyanotoxins may contribute to human neurodegenerative disease (Metcalf & Codd, 2009 ).
The exact mechanism behind MCs neurotoxicity is not known. Potent inhibition of serineand threonine-specific protein phosphatases (PPs) 1 and 2A appear to be one of the main events in MCs-induced neurotoxicity (MacKintosh et al., 1990) . Recently, MCs-congener-associated PP inhibition has been demonstrated in primary murine whole brain cells and cortical neurons (Feurstein et al., 2009 (Feurstein et al., , 2010 Rudrabhatla et al., 2009) . Consistent with this, Wang et al. (2010) revealed that the serine/threonine-specific protein phosphatase pathway, oxidative stress, and dysfunction of cytoskeletal assembly may be involved in the action of MCLR in the brain. More recently, investigations in primary murine cerebellar granule neurons showed that MCs exposure induced cytotoxicity, caspase-dependent apoptosis, and microtubule-associated tau protein hyperphosphorylation (Feurstein et al., 2011) .
Interestingly, the effects of MCs on PPs and tau suggest that MCs might be a contributor to the progression of AD. Several studies have shown that PPs are involved in the regulation of the phosphorylation of tau and neurofibrillary tangles (NF) (Goedert et al., 1995; Gong et al., 2003; Wang et al., 2001) . As the most common age-associated neurodegenerative disorder, AD is characterized by formation of NF and senile plaques, and by progressive memory loss (Ramsden et al., 2005) . The major protein component of the tangles is the hyperphosphorylated microtubule-associated protein tau (Grundke-Iqbal et al., 1986; Lee et al., 1991) .This is one of the histopathological hallmarks of AD, and is believed to be an early pathological event of AD (Braak et al., 1996) .
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The goal for this study is to identify cellular processes that contribute to the neurotoxic effects of MCs. Our previous study has indicated that intrahippocampal injection of MCLR could induce spatial learning and memory deficit, pathological impairment and oxidative stress of rats (Li et al., 2012) , suggesting that hippocampus is an important target site for neurotoxic effect of MCLR. It should be noted that most of the previous studies have been devoted to investigate the acute toxicity of MCs (Fischer and Dietrich, 2000; Li et al., 2007; Malbrouck et al., 2004; Mezhoud et al., 2008) . However, exploring the chronic effects of MCs on organisms is more relevant. This is due to chronic exposure to MCs through drinking water as the main cause of accumulation of this toxin in organisms, including human beings. MCs often amount to only a few micrograms per liter in the water of many large eutrophic lakes (Chan et al., 2007; Song et al., 2007; Gurbuz et al., 2009) . To achieve this, we chronically treated rats with MCs, and subjected the MC-treated hippocampi to analysis. Since MCLR-induced neurotoxicity is a complex process, we employed a proteomics approach in this study to be able to analyze not only variations in specific gene products but also interactions between proteins. Global protein information afforded by proteomic analysis provides great value for toxicological studies (Wetmore & Merrick., 2004; Dowling & Sheehan, 2006) , as has been demonstrated in MCs-induced toxicity studies conducted in mice, medaka fish (Oryzia sltipes), adult zebrafish (Danio rerio), zebrafish embryos, and human amnion FL cells (Chen et al., 2005; Mezhou et al., 2008; Wang et al., 2010; Li et al., 2011a , Fu et al., 2005 .
In this study, rats were chronically exposed to MCLR concentrations (1 or 10 µg/kg MCLR) for 50 d. The protein profiles of the hippocampi of exposed and non-exposed rats were analyzed using the proteomic approach, and the differentially expressed proteins were identified using 7 volume of saline solution was injected as control (n=10).
Determination of MCLR concentration in larvae
Extraction and quantitative analysis of the MCLR content in rat hippocampi (0.2 g lyophilized sample for each MCLR-exposed group) exposed to MCLR (0, 1 and 10 µg/kg) was performed as described in the previous study (Wang et al., 2008a) .
Proteomic analysis
Proteins were extracted from rat hippocampi and 2-DE analysis was performed according to the method that we reported previously with slight modifications (Li et al., 2011a) . Briefly, after protein extraction, the first dimension was carried out using 18 cm pH 4-7 IPG gel strips and 350 µL of sample solution. This pH range allowed proteins with similar isoelectric points (pI) to be separated with high resolution. After isoelectric focusing (IEF), the gels were subjected to a second dimensional electrophoresis on 12.5% polyacrylamide gels. In the second dimension, proteins were separated based on their molecular weight. At last, the protein spots were visualized via either silver staining or Coomassie brilliant blue G-250 staining. After gel image analysis, matrix-assisted laser desorption/ionization-time-of-flight (MALDI)-TOF mass spectrometry (MS)/MS was used to identify proteins that had changed significantly in quantity. The criterion for significant changes in protein expression was differences of at least 2-fold (≥ 2-fold or ≤ 0.5-fold) between the treated and control groups. Triplicate 2-DE gels were performed for each group.
Bioinformatics
Peptide mass fingerprints coupled with peptide fragmentation patterns were used to identify the protein in the National Center for Biotechnology Information (NCBI) nonredundant (nr) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 8 (http://www.matrixscience.com). The functions and specific processes of the identified proteins were matched by searching Gene Ontology (www.geneontology.org). Metabolic pathways were identified by using KEGG PATHWAY (http://www.genome.jp/kegg/pathway.html) using the method described by Colbourne et al. (2011) .
Western blot analysis
Western blotting analysis was performed using a modified version of our previous protocols (Li et al., 2011b) . About 20 mg of protein from each sample was denatured, electrophoresed, and transferred onto a polyvinylidenedifluoride (PVDF) membrane. After blocking, the blots were incubated in specific antibodies against septin 5, α-internexin, α-synuclein, and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Abcam, U.K.). They were then incubated in secondary antibodies according to the manufacturer's instructions. The protein signal was evaluated usingthe NBT/BCIP system. The results of Western blot analysis were quantified with Gene Snap software (Syngene, U.S.).
Gene expression
Total RNA isolation, synthesis of first-strand cDNA, and QPCR were performed followed the method described in our previous study (Li et al., 2011b) . The corresponding mRNA levels of three differentially expressed important proteins were examined by QPCR to validate the protein expression. GAPDH was chosen as an internal control to normalize the data. After verifying that the amplification efficiencies of the selected genes and GAPDH were approximately equal, differences in expression levels were calculated using the 2 -∆∆Ct method. The primers of tested genes were listed in Table S1 . 
Phosphatase activity analysis

Behavioral testing
The Morris Water Maze experiment was used to probe changes in spatial learning and memory in the rats (Brandeis et al., 1989) . The water maze consisted of a metal circular pool (diameter 120 cm, height 80 cm), in which a circular Plexiglas platform (diameter 10 cm, height 40 cm) was hidden 1-2 cm below the surface of the water (26±1°C). The training session consisted of 4 trials in total (one trial per quadrant) with a 30 s inter-trial interval. Trials were performed once per day for five days. Each trial was initiated by placing the rat in one of four randomly chosen locations facing the wall of the tank. Rats were allowed to search for the hidden platform for a period of 60 s. If the rat failed to find the platform, it was placed on the platform by the experimenter. As the rats swam around the pool, various parameters, such as the time taken to reach the platform and swimming paths, were record by a video imaging analysis system. On the sixth day, a probe test was performed to measure the retention of spatial memory when the platform was removed. The time spent in the target quadrant was recorded.
Light microscopy observation and TUNEL assay
At the end of behavioral test, the rats were deeply anesthetized with chiloral hydrate (350 10 mg/kg, i.p.) and perfused transcardially with 100 ml saline followed by phosphate buffer (0.1 mol/l PBS, pH 7.4) of 4% paraformaldehyde 400 ml. Then paraffin-embedded, coronal, and serial sections (4 µm thick) were taken from each brain. The sections selected from the same layer in each rat were stained with hematoxylin and eosin, and evaluated using a light microscope (×100)
by an examiner blinded to experimental conditions.
Terminal deoxynucleotidyl transferase-mediated (dUTP) nick end-labeling (TUNEL) was conducted on a paraffin-embedded section of hippocampi from experimental groups by using an in situ cell death detection kit (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's instructions. Four-micrometer sections were then treated with proteinase K (20 µg/ml in 10 mM Tris·Cl, pH 7.6, for 15 min at room temperature), blocked in 3% H 2 O 2 in methanol for 10 min, permeabilized for 2 min in 0.1% Triton X-100/sodium citrate at 4 °C, and treated with TUNEL reaction mixture. Slides were viewed and analyzed using the light microscope and Improvision Open Lab version 3.1.6 software.
Statistical analysis
Statistical analyses were performed using SPSS 16.0. Quantitative data were depicted as means with standard errors of the mean (SEM). Group differences in the escape latency in the Morris water maze training task were analyzed using two-way analysis of variance (ANOVA) with repeated measures. One-way ANOVA followed by the Duncan multiple group comparison was used to analyze group differences of the other data, P values<0.05 were defined as statistically significant.
Results
Level of MCLR in tissue
Page 10 of 39 Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 11 Levels of MCLR in rat spatial learning and memory exposed to 10 µg/kg MCLR were as high as 41.6±8.45 ng/g DW (Fig. 1) . No MCLR was detected in the tissues of untreated controls or in the group treated with 1 µg/kg MCLR.
Proteome analysis
To understand how MCLR could affect spatial learning and memory in the rats through changes in protein expression, protein samples from the hippocampi of untreated rats and of rats treated with two different concentrations of MCLR were subjected to 2-DE. Quantitative spot comparisons were made with image analysis software. On average, more than 2950 protein spots were detected in each gel. A total of 50 protein spots were found on the 2-DE gels of MCLR-exposed rat hippocampi but not on those of unexposed rat hippocampi ( Fig. 2 ) and (Table   S2 ). These proteins were found to differ significantly in abundance (≥ 2-fold or ≤ 0.5-fold; P< 0.05) in all three groups. These altered protein spots were excised for identification using MALDI-TOF-TOF MS. All of the protein spots were successfully identified with C.I.% (confidence interval%) values greater than 95%.
Metabolic pathways were identified by using KEGG PATHWAY (Fig. S1 ). Map of global KEGG metabolic pathway in rat showing significantly altered proteins in metabolic pathways.
Based on metabolic pathway analysis combined with Go annotation, we concluded that the functions of these proteins are as shown in Fig. 3 . Of the identified proteins, 12 proteins were characterized as cell cytoskeleton proteins, corresponding to cytoskeleton-, microtubule, microfilament, intermediate filament, and dynein-related proteins. Eight proteins (spots A10, A21, B13, B16, B21, C06, D08 and D21) were found to be involved in neurodegenerative diseases.
Eight proteins (spots A18, A20, B11, B22, C02, C03, C07 and D03) were characterized as 
Verification of differentially expressed proteins by Western blot analysis and gene expression
To better understand the mechanism behind MCLR-induced toxicity, we focused on characterizing the proteins, septin 5, α-internexin and α-synuclein due to the correlation of these proteins with neurodegeneration. As shown in Fig. 4 , the Western blot results and changes in QPCR expression of the selected proteins were consistent with the results of 2-DE and silver staining. These results demonstrated that the proteomic analysis of the present study was plausible.
Effects of MCLR on PP and hyperphosphorylation of tau
MCLR is a selective serine/threonine protein phosphatase inhibitor, in our study, injection of MCLR (10 µg/kg) induced approximately 25.6±4.1% inhibition of PPs (Fig. 5A ). To test whether the decrease in PPs activity could regulate the phosphorylation of tau, we examined the phosphorylation level of tau in rat hippocampi. Western blotting and quantitative analysis indicated that the immunoreactivity of pS396 and pS404 were enhanced ( Fig. 5B ), suggesting that MCLR-injection induces tau hyperphosphorylation at Ser396 and Ser404. However, it did not alter the level of total tau as determined by phosphorylation-independent monoclonal antibody tau-5.
Effects of intraperitoneal MCLR on spatial memory in rats
To determine whether the MCLR-induced inhibition of PPs and hyperphosphorylation of tau would produce memory deficits, we examined the spatial memory of rats after 50 d of MCLR exposure using a water maze. Chronic (50 d) MCLR treatment (1 and 10 µg/kg) did not influence water and food intake, body weight and overall mobility (Fig. S2 ). It also seems that the treatment Page 12 of 39 Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13 did not cause visual and locomotor deficits in rats of all groups as judged by latency of escape to a visible platform (Fig 6B) and swimming speed (Fig 6D) . In the acquisition trials, typical swimming paths on the fifth training day (Fig. 6 Aa,b,c) indicate that rats treated with MCLR took longer to find the platform than the control saline-treated rats. Fig. 6B shows the mean escape latency in Morris water maze over 5 consecutive days. As can be seen, all animals showed a progressive decline in escape latency with training. A two-way ANOVA of escape latencies for the training days revealed significant main effects of both factors: group (F(2,18)=32.63, p<0.05), and day (F(4,72)=46.17, p<0.05). Thus, MCLR treatment markedly impaired an acquisition of the water maze task. A post hoc Fisher's PLSD test indicated that MCLR (1 and 10 µg/kg) groups performed significantly worse than the control group mainly over the late days (p<0.05). In the probe trials, the swimming paths (Fig. 6 Ad,e,f) and the time spent in each quadrant (Fig. 6C ) were used to estimate performance. Results demonstrated that the rats in the control group spent significantly more time in the target quadrant than did the rats treated with MCLR at doses of 1, 10 µg/kg when the hidden platforms were removed on the day of the test. (p<0.05). Effects of
MCLR on neuronal degenerative changes and apoptosis in rat hippocampi
Histological examination and TUNEL staining were used to examine pathological changes and apoptosis. No significant neuronal abnormalities were observed in the hippocampi of the control group (Fig. 7A ), but 10 µg/kg MCLR injection induced degeneration of neurons in the hippocampi and neuronal disarray. The bodies of the neurons became short and deeply stained with dye (Fig. 7C) . We also determined whether MCLR injection could cause apoptosis using TUNEL staining. As shown in Fig. 7F , MCLR-treated rats saw a significant increase in the number of apoptotic cells in the hippocampal CA1 region.
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Discussion
In this study, to mimic the environmental exposure of MCLR to human beings, we analyzed the long term effects of 50 d of exposure to MCLR on rat hippocampi. Rats were intraperitoneally injected with different concentrations of MCLR or with a control substance. Differentially expressed proteins were investigated by 2-D gel analysis and mass spectrometry. We showed that these proteins were involved in cytoskeleton, neurodegenerative disease, oxidative stress, apoptosis, and metabolism. MCLR was also found to inhibit protein phosphatase activity and induce AD-like hyperphosphorylation of tau and spatial memory retention deficits in rats. These findings suggest possible mechanisms for impaired memory and cognitive function, such as those previously reported in rats after intra-hippocampal infusion of a MCLR variant (Maidana et al., 2006) . They are considered to be relevant to AD.
The MCs content in the aquatic environment is generally low. However, MCs can bioaccumulate in fish, mammals and even human beings through the food web (Sahin et al., 1996; Chen et al., 2009 ). This ultimately leads to the higher MCs levels in these organisms. The average MCs content in the brains of Carassius gibelio in 13 Greeklakes was 43.8 ng/g DW (Papadimitriou et al., 2010) . MCs in serum samples of fishermen at Lake Chaohu were found to be about 0.39 ng/ml (Chen et al., 2009) . In this study, the level of MCLR in the hippocampi of rats exposed to high doses of MCLR (10 µg/kg) was 41.6 ng/g DW, which is similar to the level found in tissue samples from fish and humans. In this way, the results obtained in the present study could be applied to species living with environmental exposure to MCLR.
Data from the present study showed that chronic exposure to MCLR could alter the levels of proteins associated with the cytoskeleton, oxidative stress, neurodegenerative disease, apoptosis, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 and energy metabolism in the hippocampi. The toxic effects of MCLR on the cytoskeletal structures have been extensively investigated in different cell types (Gácsi et al., 2009; Lankoff et al., 2003; Toivola et al., 1997; Wickstrom et al., 1995) . Recently, it has been reported that MCLR triggered reorganization of microtubule and actin cytoskeleton components, leading to a loss of their filamentous distribution (Meng et al., 2011) . In agreement with the prior findings, our study demonstrated that MCLR could induce varied expression of the cytoskeleton and its associated proteins in rat hippocampi, indicating that the neurotoxicity of MCLR involves disruption of the neuronal cytoskeletal architecture. Previous evidence has demonstrated that MC can produce oxidative stress by generating reactive oxygen species (ROS) and altering the antioxidant defense system (Ding et al., 2000 (Ding et al., , 2001 Li et al., 2003; Prieto et al., 2007; Amado et al., 2009 ). Six proteins (GFAP, Hsp70, Hsp75, Prdx2, SOD, and Stip1) identified in our study can be assigned to oxidative stress and apoptosis response. These proteins were found to be significantly induced, indicating disturbance in the pro-oxidant/antioxidant balance of the rat hippocampi after exposure to MCLR. It has been suggested that HSP induction may be an early marker of oxidative stress.
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Antioxidant enzymes such as SOD and Prdx2 constitute the major defensive system against ROS (Sies, 1993) . They alleviate the toxic effects of ROS by scavenging free radicals and ROS. The activation of antioxidant enzymes and induction of HSP suggest increased oxidative stress in the rat hippocampus.
In the current study, we found that MCLR exposure increased the expression of several proteins known to be related to neurodegenerative disease, such as septin 5, α-internexin, and α-synuclein, in the hippocampi of rats. Mammalian septin 5 (also called CDCrel-1) is a member of the septin family, comprising GTPases required for the completion of cytokinesis in diverse (Field et al., 1996; Trimble, 1999) . Munoz et al., 1988; Sasaki et al., 1989; Galloway et al., 1992; Trojanowski & Lee, 1994) . It has also been reported that over-expression of α-internexin results in motor coordination deficitsin transgenic mice and in neuronal death in the rat adrenal pheochromocytoma cell line PC12 (Ching et al., 1999; Chien et al., 2005) . α-synuclein (also known as the non-Aβ component of AD amyloid, NACP) is a major histopathological hallmark of several neurodegenerative disorders, which are now defined as synucleinopathies. It is mainly localized in presynaptic terminals (Burre et al., 2010) . It was originally found in the brains of human AD patients. α-synuclein has been found to accumulate abnormally in synaptic terminals and axons in PD, DLB, and multiple system atrophy (MSA) (Goedert, 2001 ). The induction of septin 5, α-internexin and α-synuclein observed in this study illustrates that MCLR might be a contributor to the progression of AD.
As a principal neuronal microtubule-associated protein, tau has been found to play major 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 17 roles in promoting microtubule assembly, stabilization and in maintaining normal neuron morphology (Wang & Liu, 2008) . Several studies have shown that PPs is involved in the regulation of the phosphorylation of tau and NF (Goedert et al., 1995; Tian & Wang, 2002; Sun et al., 2003) . Inhibition of PPs in neurons induces abnormal hyperphosphorylation and aggregation of tau similar to that observed in the brains of AD patients (Sontag et al., 1996; Kim et al., 1999; Gong et al., 2000; Sun et al., 2003) . Down-regulation of PPs, which appears to lead to hyperphosphorylation of tau and NF proteins and consequently to neurofibrillary degeneration, has been observed in the affected areas of AD brains (Volgelsberg-Ragaglia et al., 2001) . In this study, we demonstrated that significant inhibition of PPs by MCLR increased tau phosphorylation levels at Ser396 and Ser404. It has been reported that phosphorylation of tau at Ser396 and Ser404 sites is positively correlated with memory impairment in rats (Wang et al., 2008b) . In the present study, we also observed that intraperitoneal injection of MCLR for 50 d can induce impairment of learning and memory, accompanied by severe histological damage and neuronal apoptosis in the CA1 regions of the hippocampal neurons in rats. Our results suggest that down-regulation of PPs is an early critical event leading to not only abnormal hyperphosphorylation of tau but also to the impairment of memory and cognitive function associated with AD.
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